|
COPB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.10639999999441E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.030200E-04 |
| Normal-vs-Stage2 |
1.923900E-03 |
| Normal-vs-Stage3 |
3.5286999999995E-05 |
| Normal-vs-Stage4 |
4.29239999999442E-06 |
| Stage1-vs-Stage2 |
4.715200E-01 |
| Stage1-vs-Stage3 |
1.149190E-01 |
| Stage1-vs-Stage4 |
6.950100E-02 |
| Stage2-vs-Stage3 |
7.001200E-01 |
| Stage2-vs-Stage4 |
4.120400E-01 |
| Stage3-vs-Stage4 |
5.752800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.67580000000256E-05 |
| Normal-vs-AfricanAmerican |
1.338150E-01 |
| Normal-vs-Asian |
1.798190E-03 |
| Caucasian-vs-AfricanAmerican |
2.049200E-01 |
| Caucasian-vs-Asian |
8.858800E-01 |
| AfricanAmerican-vs-Asian |
3.236800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.26449999999323E-05 |
| Normal-vs-Female |
2.242700E-04 |
| Male-vs-Female |
1.657380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.624400E-03 |
| Normal-vs-Age(41-60Yrs) |
7.80350000000318E-05 |
| Normal-vs-Age(61-80Yrs) |
1.91059999998799E-06 |
| Normal-vs-Age(81-100Yrs) |
1.636450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.223800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.501760E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.393400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.939000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.607600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.542400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.754200E-01 |
| Classical-VS-Follicular |
1.300190E-01 |
| Classical-VS-Other |
1.570160E-01 |
| Classical-VS-Normal |
7.647300E-04 |
| Tall-VS-Follicular |
9.641400E-01 |
| Tall-VS-Other |
3.970800E-01 |
| Tall-VS-Normal |
1.139190E-03 |
| Follicular-VS-Other |
5.028000E-01 |
| Follicular-VS-Normal |
1.402840E-04 |
| Other-VS-Normal |
6.141200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.00109999999709E-05 |
| Normal-vs-N1 |
3.62560000000123E-05 |
| N0-vs-N1 |
3.909200E-01 |
|
|
